Robert Plenge MD, PhD
Bristol Myers Squibb
Robert is Senior Vice President, Research & Early Development and Head of Immunology, Cardiovascular, & Fibrosis Thematic Research Center (ICF TRC) and Translational Medicine (TM) at Bristol Myers Squibb (BMS). Within the ICF TRC, Robert is responsible for the strategic vision, implementation, and partnership of novel therapies from discovery through proof-of-concept clinical trials for immunologic, CV and fibrotic diseases. Within TM, Robert is responsible for diagnostics and late development translational plans across all therapeutic areas at BMS, including oncology and hematology. Together,